Infection route of hepatitis C patients treated with direct-acting antivirals -To evaluate the risk of reinfection--Reference-Cited by-同舟云学术

Infection route of hepatitis C patients treated with direct-acting antivirals -To evaluate the risk of reinfection-

Published:2017 Issue:8 Volume:58 Page:435-440
ISSN:0451-4203
Container-title:Kanzo
language:en
Short-container-title:Acta hepatologica Japonica

Author:

Yukawa Yoshimi¹,Tamori Akihiro¹,Teranishi Yuga¹,Motoyama Hiroyuki¹,Kozuka Ritsuzo¹,Kawamura Etsushi¹,Hagihara Atsushi¹,Uchida-Kobayashi Sawako¹,Morikawa Hiroyasu¹,Enomoto Masaru¹,Murakami Yoshiki¹,Fukushima Wakaba²,Kawada Norifumi¹

Affiliation:

1. Department of Hepatology, Graduate School of Medicine, Osaka City University

2. Department of Public Health, Graduate School of Medicine, Osaka City University

Publisher

Japan Society of Hepatology

Subject

Hepatology

Link

https://www.jstage.jst.go.jp/article/kanzo/58/8/58_435/_pdf

Reference9 articles.

1. 1) Simmons B, Saleem J, Hill A, et al. Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis. Clinical Infectious Diseases 2016; 62: 683-694

2. 2) Midgard H, Bjoro B, Maeland A, et al. Hepatitis C reinfection after sustained virological response. J Hepatol 2016; 64: 1020-1026

3. 4) Hope VD, Eramova I, Capurro D, et al. Prevalence and estimation of hepatitis B and C infections in the WHO European Region: a review of data focusing on the countries outside the European Union and the European Free Trade Association. Epidemiol Infect 2014; 142: 270-286

4. 5) Satoh Y, Hino K, Kato T, et al. Molecular epidemiologic analysis of hepatitis C virus infection in injecting drug users with acute hepatitis C in Japan. J Gastroenterol Hepatol 2004; 19: 1305-1311